The BioCentury Show
The BioCentury Show
BioCentury
Ep. 55 - Bruce Booth: Biotech Benefiting from Belt-Tightening
32 minutes Posted Apr 17, 2024 at 9:00 pm.
Intro01:54 - Capital Markets07:19 - How to Pitch a VC12:12 - Obesity 16:30 - New Modalities22:28 - Industry Efficiency, AI
0:00
32:10
Download MP3
Show notes
This is a previously recorded episode of The BioCentury Show. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes.Atlas Venture’s Bruce Booth believes the belt-tightening by biotechs in the past few years will presage a better financing outlook for companies, but the ripple effects will be felt for some time to come. In conversation with Editor in Chief Simone Fishburn on The BioCentury Show, the longtime biotech VC said that there are clear positive signs for biotech, with the XBI ETF bouncing back from its lows in the 60s, February’s robust follow-on financing market and a stream of M&A deals. “Everybody did belt-tightening the last few years,” said Booth. “So, you’re coming from a good place in terms of overall burn rates, and companies, I think, are in a good place to be financed by the next wave of investors.”View full story: https://www.biocentury.com/article/651821#biotech #pharma #biopharma #lifescience #TheBioCenturyShow 00:00 - Intro01:54 - Capital Markets07:19 - How to Pitch a VC12:12 - Obesity 16:30 - New Modalities22:28 - Industry Efficiency, AI